This is the first experimental in vivo study that shows that chronic treatment with ANP reduces cardiac oxidative stress, fibrosis, apoptosis and hypertrophy in a model of hypertension, increasing NO-system activity. This evidence concerns the gene NPPA and hypertensive disorder.